Search Results - "Schlifke, Irene"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Seizure Suppression by GDNF Gene Therapy in Animal Models of Epilepsy by Kanter-Schlifke, Irene, Georgievska, Biljana, Kirik, Deniz, Kokaia, Merab

    Published in Molecular therapy (01-06-2007)
    “…Temporal lobe epilepsy patients remain refractory to available anti-epileptic drugs in 30% of cases, indicating a need for novel therapeutic strategies. In…”
    Get full text
    Journal Article
  2. 2
  3. 3

    VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures by Nikitidou, Litsa, Kanter-Schlifke, Irene, Dhondt, Joke, Carmeliet, Peter, Lambrechts, Diether, Kokaia, Mérab

    Published in PloS one (12-07-2012)
    “…Vascular endothelial growth factor (VEGF) was first described as an angiogenic agent, but has recently also been shown to exert various neurotrophic and…”
    Get full text
    Journal Article
  4. 4

    NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning by Sørensen, Andreas T., Kanter-Schlifke, Irene, Carli, Mirjana, Balducci, Claudia, Noe, Francesco, During, Matthew J., Vezzani, Annamaria, Kokaia, Merab

    Published in Hippocampus (01-01-2008)
    “…Recombinant adeno‐associated viral (rAAV) vector‐induced neuropeptide Y (NPY) overexpression in the hippocampus exerts powerful antiepileptic and…”
    Get full text
    Journal Article
  5. 5

    Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP by Sørensen, Andreas T., Nikitidou, Litsa, Ledri, Marco, Lin, En-Ju D., During, Matthew J., Kanter-Schlifke, Irene, Kokaia, Merab

    Published in Experimental neurology (01-02-2009)
    “…Recently, hippocampal neuropeptide Y ( NPY) gene therapy has been shown to effectively suppress both acute and chronic seizures in animal model of epilepsy,…”
    Get full text
    Journal Article
  6. 6

    GDNF released from encapsulated cells suppresses seizure activity in the epileptic hippocampus by Kanter-Schlifke, Irene, Fjord-Larsen, Lone, Kusk, Philip, Ängehagen, Mikael, Wahlberg, Lars, Kokaia, Merab

    Published in Experimental neurology (01-04-2009)
    “…To date, a variety of pharmacological treatments exists for patients suffering epilepsy, but systemically administered drugs offer only symptomatic relief and…”
    Get full text
    Journal Article
  7. 7

    Brain area, age and viral vector-specific glial cell-line-derived neurotrophic factor expression and transport in rat by Kanter-Schlifke, Irene, Georgievska, Biljana, Kirik, Deniz, Kokaia, Merab

    Published in Neuroreport (11-06-2007)
    “…We investigated the feasibility of viral vector-mediated expression and axonal transport of the glial cell-line-derived neurotrophic factor, a potential…”
    Get full text
    Journal Article
  8. 8

    Making the patient voice heard in a research consortium: experiences from an EU project (IMI-APPROACH) by Taylor, Jane, Dekker, Sjouke, Jurg, Diny, Skandsen, Jon, Grossman, Maureen, Marijnissen, Anne-Karien, Ladel, Christoph, Mobasheri, Ali, Larkin, Jon, Weinans, Harrie, Kanter-Schlifke, Irene

    Published in Research involvement and engagement (10-05-2021)
    “…APPROACH is an EU-wide research consortium with the goal to identify different subgroups of knee osteoarthritis to enable future differential diagnosis and…”
    Get full text
    Journal Article
  9. 9

    Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum by Sørensen, Andreas T., Kanter-Schlifke, Irene, Lin, En-Ju D., During, Matthew J., Kokaia, Merab

    Published in Molecular and cellular neuroscience (01-10-2008)
    “…Neuropeptide Y (NPY) gene transduction of the brain using viral vectors in epileptogenic regions can effectively suppress seizures in animals, and is being…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Upregulation of cytokine mRNA in circulating leukocytes during human endotoxemia by Jilma-Stohlawetz, Petra, Kliegel, Tuende, Kantner-Schlifke, Irene, Strasser-Marsik, Claudia, Mayr, Florian B, Jilma, Bernd

    Published in European cytokine network (01-03-2017)
    “…Endotoxemia induces pronounced changes in leukocyte count and enhances the release of many cytokines. However, the molecular regulation of this cytokine…”
    Get full text
    Journal Article
  14. 14

    VEGF Receptor-2 by Nikitidou, Litsa, Kanter-Schlifke, Irene, Dhondt, Joke, Carmeliet, Peter, Lambrechts, Diether, Kokaia, Mérab

    Published in PloS one (12-07-2012)
    “…Vascular endothelial growth factor (VEGF) was first described as an angiogenic agent, but has recently also been shown to exert various neurotrophic and…”
    Get full text
    Journal Article
  15. 15

    Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia by Derhaschnig, Ulla, Bergmair, Doris, Marsik, Claudia, Schlifke, Irene, Wijdenes, John, Jilma, Bernd

    Published in Critical care medicine (01-05-2004)
    “…OBJECTIVE:Clinical trials show that interleukin (IL)-6 represents a predictive marker in human sepsis. Furthermore, IL-6 has been proposed as a candidate…”
    Get full text
    Journal Article
  16. 16

    Galanin expressed in the excitatory fibers attenuates synaptic strength and generalized seizures in the piriform cortex of mice by Schlifke, Irene, Kuteeva, Eugenia, Hokfelt, Tomas, Kokaia, Merab

    Published in Experimental neurology (01-08-2006)
    “…The neuropeptide galanin is considered to be an endogenous antiepileptic agent, presumably acting via inhibition of glutamate release. Previously, we have…”
    Get full text
    Journal Article
  17. 17

    Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity by Kanter-Schlifke, I, Toft Sørensen, A, Ledri, M, Kuteeva, E, Hökfelt, T, Kokaia, M

    Published in Neuroscience (19-12-2007)
    “…Abstract Gene therapy–based overexpression of endogenous seizure-suppressing molecules represents a promising treatment strategy for epilepsy. Viral…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level by Marsik, Claudia, Halama, Thomas, Cardona, Francesco, Schlifke, Irene, Mittermayer, Friedrich, Jilma, Bernd

    Published in Clinical immunology (Orlando, Fla.) (01-03-2005)
    “…Interleukin 6 (IL-6) performs a prominent role during sepsis. To examine the molecular regulation of IL-6, IL-6 receptor, and signaling receptor gp130 during…”
    Get full text
    Journal Article